Table 6.
Study | Design | No. of Patients (ESWT/Control Group) |
Measurement | Intragroup Difference | Intergroup Difference | |
---|---|---|---|---|---|---|
Mahran et al., 2015 (Egypt) [38] | RCT | ESWT + CDT: 20 | Total circumferential differences | 20 cm AE 15 cm AE 10 cm AE 10 cm BE 15 cm BE 20 cm BE |
Yes | Yes |
CDT: 20 | Yes | |||||
Abdelhalim et al., 2018 (Egypt) [41] | RCT | ESWT + CDT: 30 | Difference of healthy and affected arm | 10 cm below axilla 10 cm AE 7 cm BE 7 cm above wrist |
Yes | Yes |
CDT: 30 | Yes | |||||
Lee et al., 2020 (South Korea) [42] | RCT | ESWT + CDT: 15 | Affected arm | 10 cm AE Elbow 10 cm BE Wrist MCP |
Yes (only 10 cm BE) |
No |
CDT: 15 | No | |||||
Cebicci et al., 2021 (Turkey) [43] | RCT | ESWT: 10 | Difference of healthy and affected arm | 15 cm AE 10 cm BE Wrist MCP |
Yes | No |
CDT: 10 | Yes (only 10 cm BE and wrist) |
|||||
Joos et al., 2020 (Belgium) [44] | Prospectivepilot study | ESWT + CDT: 10 | Affected arm | 10 cm AE Elbow 10 cm BE |
No | N/A |
Abbreviations: ESWT: Extracorporeal shock wave therapy; BCRL: Breast cancer-related lymphedema; No.: Number; RCT: Randomized controlled trial; CDT: Complex decongestive therapy; cm: centimeter; AE: Above elbow; BE: Below elbow; MCP: Netacarpophalangeal joint; N/A: Not available.